New research signals a promising advance in endometriosis diagnosis

MedicalXpress | 四月 29, 2026

The Nuffield Department of Women's & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited, announces the publication of Phase 2 data in The Lancet Obstetrics and Gynaecology. The findings highlight the potential of the novel molecular imaging agent, 99mTc-maraciclatide, as a non-invasive tool for the diagnosis and monitoring of endometriosis.